High degree of multi-drug resistance and hetero-resistance in pulmonary TB patients from Punjab state of India

Tuberculosis

Volumn 94, Issue 1, 2014, Pages 73-80

  Kumar, Parveen ^a   Balooni, Veena ^a   Sharma, Brijesh Kumar ^a   Kapil, Virender ^a   Sachdeva, K S ^b   Singh, Sarman ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b GOVERNMENT OF INDIA   (India)

Author keywords

Isoniazid; Line Probe Assay; MTBDRplus; Mycobacterium tuberculosis; Rifampicin

Indexed keywords

ARTICLE; BACTEC MGIT 960 SYSTEM; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG SENSITIVITY; GENOTYPE; HUMAN; INDIA; INTERMETHOD COMPARISON; KATG GENE; LINE PROBE ASSAY; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RPOB GENE; SAMPLE SIZE; SCREENING TEST; SPUTUM ANALYSIS; WILD TYPE;

ISONIAZID; LINE PROBE ASSAY; MTBDRPLUS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPICIN;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; MYCOBACTERIUM TUBERCULOSIS; SEQUENCE ANALYSIS, DNA; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84891558651     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2013.10.001     Document Type: Article

References (50)

1. World Health Organization Tuberculosis in the South-East Asia Region: the regional report 2012 WHO Geneva SEA/TB/338. Retrieved from: http://whothailand.healthrepository.org/handle/123456789/1430
2. Revised National Tuberculosis Control Programme Response to challenges of drug resistant TB in India January 2012 (Update 2012) 2012 Retrieved from: http://www.tbcindia.nic.in/pdfs/RNTCP%20Response%20DR%20TB%20in%20India%20- %20Jan%202012%20update.pdf
3. Stop TB Partnership The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis 2010 WHO Press Geneva, Switzerland Retrieved from: http://www.stoptb.org/assets/documents/global/plan/TB-Global Plan ToStopTB2011-2015.pdf
4. P. Singh, and V.M. Katoch Multi-drug resistant tuberculosis: current status and emerging tools for its management in India J Commun Dis 38 2006 216 229
5. J. Makinen, H.J. Marttila, M. Marjamäki, M.K. Viljanen, and H. Soini Comparison of two commercially available DNA line probe assays for detection of multidrug-resistant Mycobacterium tuberculosis J Clin Microbiol 44 2006 350 352 (Pubitemid 43222221)
6. World Health Organization Use of liquid TB culture and drug susceptibility testing (DST) in low and medium-income settings 2007 World Health Organization Geneva
7. World Health Organization Policy statement. Molecular line probe assay for rapid screening of patients at risk of multidrug-resistant (MDR) TB 2008 Geneva. Retrieved from: http://www.who.int/tb/features-archive/policy-statement. pdf
8. World Health Organization Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system 2011 Retrieved from: http://www.who.int/tb/features-archive/xpert-rapid-tb-test/en/index.html
9. R. Rossau, H. Traore, H. De Beenhouwer, W. Mijs, G. Jannes, P. De Rijk, and F. Portaels Evaluation of the INNO-LiPA Rif TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin Antimicrob Agents Chemother 41 1997 2093 2098 (Pubitemid 27422196)
10. M. Morgan, S. Kalantri, L. Flores, and M. Pai A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis BMC Infect Dis 5 2005 62
11. A. Telenti, N. Honore, C. Bernasconi, J. March, A. Ortega, B. Heym, H.E. Takiff, and S.T. Cole Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level J Clin Microbiol 35 1997 719 723 (Pubitemid 27083868)
12. Hain Lifescience GmbH GenoType MTBDRplus, version 1.0 [product insert] 2007 http://www.hain-lifescience.com/pdf/304xx-pbl.pdf Nehren, Germany
13. S. Hofmann-Thiel, J. van Ingen, K. Feldmann, L. Turaev, G.T. Uzakova, G. Murmusaeva, D. Soolingen, and H. Hoffmann Mechanisms of hetero resistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan Eur Respir J 33 2009 368 374
14. J.Q. Farooqi, E. Khan, S.J.M. Alam, A. Ali, Z. Hasan, and R. Hasan Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan J Pak Med Assoc 62 2012 767 772
15. R. Singhal, J. Arora, P. Lal, M. Bhalla, V.P. Myneedu, and D. Behera Comparison of line probe assay with liquid culture for rapid detection of multidrug resistance in Mycobacterium tuberculosis Indian J Med Res 136 2012 1044 1047
16. Revised National Tuberculosis Control Programme Guidelines on programmatic management of drug resistant TB (PMDT) in India, May 2012 2012 Retrieved from: http://www.tbcindia.nic.in/pdfs/ Guidelines%20for%20PMDT%20in%20India%20-%20May%202012.pdf
17. Hain Lifescience GmbH, Nehren, Germany. GenoType MTBDRplus, version 2.0 [product insert] http://www.hain-lifescience.de/en/instructions-for-use.html.
18. K. Gopinath, and S. Singh Multiplex PCR assay for simultaneous detection and differentiation of Mycobacterium tuberculosis, Mycobacterium avium complexes and other mycobacterial species directly from clinical specimens J App Microbiol 107 2009 425 435
19. Becton and Dickinson, USA. BACTEC MGIT-960 SIRE kit for the anti-mycobacterial susceptibility testing of Mycobacterium tuberculosis. Retrieved from: http://www.bd.com/ds/technicalCenter/clsi/clsi-960sire.pdf.
20. Hain Lifescience GmbH, Nehren, Germany. GenoLyse [product insert]. http://www.hain-lifescience.de/en/instructions-for-use.html.
21. P.J. Campbell, G.P. Morlock, R.D. Sikes, T.L. Dalton, B. Metchock, A.M. Starks, D.P. Hooks, L.S. Cowan, B.B. Plikaytis, and J.E. Posey Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis Antimicrob Agents Chemother 55 2011 2032 2041
22. C. Cavusoglu, A. Turhan, P. Akinci, and I. Soyler Evaluation of the GenoType MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates J Clin Microbiol 44 2006 2338 2342 (Pubitemid 44092395)
23. D. Hillemann, M. Weizenegger, T. Kubica, E. Richter, and S. Niemann Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates J Clin Microbiol 43 2005 3699 3703 (Pubitemid 41129648)
24. P. Miotto, F. Piana, D.M. Cirillo, and G.B. Migliori Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis J Clin Microbiol 46 2008 393 394
25. ® MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam BMC Infect Dis 10 2010 149
26. M. Barnard, H. Albert, G. Coetzee, R. O'Brien, and M.E. Bosman Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa Am J Respir Crit Care Med 177 2008 787 792 (Pubitemid 351490566)
27. D. Ling, A. Zwerling, and M. Pai GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis Eur Respir J 32 2008 1165 1174
28. H. Albert, F. Bwanga, S. Mukkada, N. Nyesiga, P. Ademun, G. Lukyamuzi, M. Haile, S. Hoffner, M. Joloba, and R. O'Brien Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda BMC Infect Dis 10 2010 41
29. S. Feuerriegel, B. Oberhauser, A.G. George, F. Dafae, E. Richter, S. Rüsch-Gerdes, and S. Niemann Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting BMC Microbiol 12 2012 90
30. M.B. Heep, U. Brandstatter, N. Rieger, E. Lehn, S. Richter, Rusch-Gerdes, and S. Niemann Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates J Clin Microbiol 39 2001 107 110 (Pubitemid 32059577)
31. N. Ozkutuk, H. Gazi, S. Surucuoglu, A. Gunduz, and B. Ozbakkaloglu Characterization of rpoB mutations by Line Probe Assay in rifampicin resistant Mycobacterium tuberculosis clinical isolates from the Aegean region in Turkey Jpn J Infect Dis 60 2007 211 213 (Pubitemid 47365044)
32. A.R. Bahrmand, P.T. Leonid, T.A. Hadizadeh, S. Yari, and A.G. Edward High-level rifampin resistance correlates with multiple mutations in the rpoB gene of pulmonary tuberculosis isolates from the Afghanistan border of Iran J Clin Microbiol 9 2009 2744 2750
33. N. Siddiqi, M. Shamim, S. Hussain, R.K. Choudhary, N. Ahmed, Prachee, S. Banerjee, G.R. Savithri, M. Alam, N. Pathak, A. Amin, M. Hanief, V.M. Katoch, S.K. Sharma, and S.E. Hasnain Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India Antimicrob Agents Chemother 46 2002 443 450 (Pubitemid 34087194)
34. M.P. Tolani, T.B. D'souza, and N.F. Mistry Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India BMC Infect Dis 12 2012 9
35. D. Rienthong, S. Rienthong, C. Boonin, S. Woraswad, and Y. Kasetjaroen Rapid detection for early appearance of rifampin and isoniazid resistance in Mycobacterium tuberculosis Siriraj Med J 61 2009 49 55
36. T. Nestani, R.K. Kempker, I. Kalandadze, E. Kurbatova, M.L. Leonard, R. Apsindzelashvili, N. Bablishvili, M. Kipiani, and H.M. Blumberg Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis PLoS One 7 2012 e31563
37. I. Mokrousov, O. Narvskaya, T. Otten, E. Limenschenko, L. Steklova, and B. Vyshnevskiy High prevalence of katG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis isolates from Northwestern Russia, 1996-2001 Antimicrob Agents Chem 46 2002 1417 1424 (Pubitemid 34415323)
38. P. Miotto, F. Piana, V. Penati, F. Canducci, G.B. Migliori, and D.M. Cirillo Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy J Clin Microbiol 44 2006 2485 2491 (Pubitemid 44092416)
39. A. Lacoma, G.N. Sierra, C. Prat, J. Ruiz-Manzano, L. Haba, S. Roses, J. Maldonado, and J. Domínguez GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples J Clin Microbiol 46 2008 3660 3667
40. P. Kiepiela, K.S. Bishop, A.N. Smith, L. Roux, and D.F. York Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwa-Zulu Natal, South Africa Tuber Lung Dis 80 2000 47 56 (Pubitemid 30179493)
41. L.V. Baker, T.J. Brown, O. Maxwell, A.L. Gibson, Z. Fang, M.D. Yates, and F.A. Drobniewski Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC-46A polymorphism Antimicrob Agents Chem 49 2005 1455 1464 (Pubitemid 40463376)
42. Z.F. Udwadia, R.A. Amale, K.K. Ajbani, and C. Rodrigues Totally drug-resistant tuberculosis in India Clin Infect Dis 15 2012 579 581
43. ® MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation BMC Clin Pathol 9 2009 2
44. D.L. Williams, L. Spring, L. Collins, L.P. Miller, L.B. Heifets, P.R. Gangadharam, and T.P. Gillis Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis Antimicrob Agents Chemother 42 1998 1853 1857 (Pubitemid 28311593)
45. A. Zaczek, A. Brzostek, E. Augustynowicz-Kopec, Z. Zwolska, and J. Dziadek Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin BMC Microbiol 9 2009 10
46. M. Bobadilla-del-Valle, A. Ponce-de-Leon, C. Arenas-Huertero, G. Vargas-Alarcon, M. Kato-Maeda, P.M. Small, P. Couary, G.M. Ruiz-Palacios, and J. Sifuentes-Osornio rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism Emerg Infect Dis 7 2001 1010 1013 (Pubitemid 33115782)
47. T. Bodmer, G. Zurcher, P. Imboden, and A. Telenti Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in vitro activity of rifampin-resistant Mycobacterium tuberculosis J Antimicrob Chemother 35 1995 345 348
48. D.B. Folkvardsen, E. Svensson, V. Thomsen, E.M. Rasmussen, D. Bang, J. Werngren, S. Hoffner, D. Hillemann, and L. Rigoutsd Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis? J Clin Microbiol 51 2013 1596 1599
49. C. Cavusoglu, S. Hilmioglu, S. Guneri, and A. Bilgic Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and Line Probe Assay J Clin Microbiol 40 2002 4435 4438 (Pubitemid 35434927)
50. A. Jain, R. Mondal, R. Prasad, K. Singh, and R.C. Ahuja Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh Indian J Med Res 128 2008 300 306